K
Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
PNK – Real Time Price. Currency in USD
39.47
0.00 (0.00%)
At close: Oct 9, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
PNK – Real Time Price. Currency in USD
39.47
0.00 (0.00%)
At close: Oct 9, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $312.4M significantly exceed its total debt $4.4M, ensuring strong financial flexibility
Total current assets $767.6M exceed Total current liabilities $234.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.6), showcasing prudent financial management
Interest coverage ratio (135x) indicates the company easily manages its debt payments
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.28 | 1.35 | 10 | |
| Quick ratio | 2.49 | 0.91 | 10 | |
| Debt to Equity | 0.00 | 0.55 | 10 | |
| Debt to Assets | 0.00 | 0.27 | 10 | |
| Interest coverage | 135.17 | 9.02 | 10 | |
| Weighted average score | 10 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.27B | 1.23B | 1.05B | 1.06B | 1.07B |
| Gross Profit | 684M | 660M | 526M | 507M | 535M |
| Operating Income | 202M | 183M | 158M | 95M | 68M |
| Net Income | 153M | 144M | 64M | 23M | 12M |
| EBITDA | 243M | 226M | 209M | 151M | 127M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | 49.95 | 50.08 | 9.0 | |
| Operating margin % | 2.19 | 12.75 | 2.0 | |
| Net margin % | 0.27 | 7.89 | 2.0 | |
| EBITDA margin % | 8.95 | 16.69 | 3.0 | |
| Cash flow margin % | N/A | 13.17 | 1.0 | |
| Weighted average score | 3.4 | |||
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| ROA | 1.93 | 6.26 | 3.0 | |
| ROE | 2.38 | 10.34 | 3.0 | |
| ROIC | 2.37 | 9.88 | 5.0 | |
| ROCE | 4.95 | 12.80 | 5.0 | |
| Weighted average score | 4.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.02 | 26.44 | 5.5 |
| Next quarter | 3 | 203.88 | 7.0 |
| Current year | 2.73 | 181.87 | 7.0 |
| Next year | 4.26 | 30.55 | 7.0 |
| Weighted average score | 6.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 7.55 | -90.47 | -90.61 | N/A | 2.3 |
| Y/Y | -9.74 | -94.19 | -94.27 | N/A | 1.0 |
| 3y average | -5.62 | -41.55 | -40.72 | -74.4 | 1.0 |
| 5y average | -6.07 | -28.68 | -27.94 | -51.9 | 1.0 |
| Weighted average score | 1.3 | ||||
| NAME | RATIO | INDUSTRY | 5Q TREND | SCORE |
|---|---|---|---|---|
| P/E | N/A | 21.63 | 1.0 | |
| PEG (5yr expected) | N/A | 2.18 | 1.0 | |
| P/S | N/A | 1.80 | 1.0 | |
| P/B | N/A | 2.54 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 1.45 | 3.04 | 5.0 |
| Payout ratio | 66.89 | 63.62 | 4.0 |
| 5-year dividend growth rate | -2.31 | 2.28 | 1.0 |
| Years of dividend increase | 9.00 | 1.00 | 7.0 |
| Weighted average score | 4.3 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | N/A | N/A |
| Intangible assets | N/A | N/A |
| Switching costs | N/A | N/A |
| Network effect | N/A | N/A |
| Economies of scale | N/A | N/A |
| Weighted average score | 1.0 | |